milvexian section,asundexian
bayer
['factor xi', 'asundexian', 'pacific-stroke']
pacific-stroke phase2 trial: in pts w/acute,non-ce ischemic stroke,inhibition of factor xia w/asundexian did not reduce composite of covert brain infarction or ischemic stroke. no dose response shown. no significant increase in risk of major or intracranial bleeding. #esccongress 
Non-Profit Founder/Leader | ?? Doc | Artist | Scientist | Educator | News Anchor https://t.co/usmuA3tKft | RT ? endorse | Disclaimer: https://t.co/bwmE2O3U5W